**Overall Verdict**

Publication-ready: **No**. The empirical core looks strong, and the Round 2 softening is real in the abstract, but the paper still has several publication-blocking overclaims and internal mismatches: the `n:m` caption is false, source-level `q<10^{-6}` is false for beta-PGD, clinical “matched/same effect size” language remains too strong, and the Paper 07 relation misstates the `5.5x` baseline comparison.

**1. Claim Audit**

There are no formal theorem/proposition environments; the non-trivial claims are empirical/methodological.

- `main.tex:33`, “separates ... `14/14` subjects, `t=7.11`, `d_z=1.90`”: internally supported by Table 1 and `main.tex:107`. Accept.
- `main.tex:33,107`, “holds under leave-one-subject-out re-standardisation”: acceptable only as **LOSO standardisation**, not LOSO feature discovery. Do not let readers confuse this with Paper 07’s cross-validated LOSO feature-reselection.
- `main.tex:143-163`, “four reach BH-FDR”: supported by Table 2. But `global_order` is later admitted to equal a baseline feature (`main.tex:169`), so it should not be called closure-specific.
- `main.tex:163`, PAC decrease as “information binding”: too interpretive. Sensor result supports a PAC decrease; source-level PAC weakens to `5/14` (`main.tex:254`) and clinical PAC is non-significant (`main.tex:283`).
- `main.tex:165`, “not transient and not ramping”: sign/mean thirds support stability, but no trend model is shown. “Not ramping” needs either a regression or softer wording.
- `main.tex:169`, “surviving regression confirms ... beyond classical spectral measures”: supports only **linear residual information beyond the chosen 7-D baselines**. Not all spectral/confound structure.
- `main.tex:197,327`, posterior-alpha refinement: overreaches. The paper measures alpha-PGD/coherence-like structure, not the conventional posterior alpha power decrease.
- `main.tex:201`, “magnitudes decreasing monotonically”: false as table values go `0.010` at `2:1` then `0.030` at `2.5:1`.
- `main.tex:218`, “Every tested ratio reaches BH-FDR significance”: false. Table says `4:1` has `q=0.10` (`main.tex:213`).
- `main.tex:227,254,258`, source localisation: source effect is real and useful, but “rule out,” “clean test,” and “cannot be explained” are still too strong given sLORETA leakage, template anatomy, and identity covariance.
- `main.tex:33,370`, “two strongest ... reach `q<10^{-6}`”: false for beta-PGD, reported as `q=2.3e-6` at `main.tex:254`.
- `main.tex:263,305,309,366`, clinical “matches/same effect size”: still too strong. In-sample `d_z=1.98` is comparable, but Paper 07 reports honest clinical LOSO `d_z=1.16`, Jaccard `0.52` (`07 main.tex:131-132`).
- `main.tex:321`, “synthetic prior was wrong direction”: plausible but under-supported in Results. Add residual-distance table/figure or quantify “substantial subset.”
- `main.tex:331`, Paper 07 relation: proxy/operator distinction is correct, and `d_z=2.07`, Jaccard `1.00` match `07 main.tex:124`. But the `5.5x` dominance is misattributed: Paper 07 says `5.5x` is source full-feature in-sample `2.58` vs baseline `0.47`, not the LOSO two-feature subset (`07 main.tex:126,368`).
- `main.tex:337`, “11 paired + 4 unpaired, 14/15”: inconsistent with current Paper 07, which says `12/12` paired including controls and `15/16` overall (`07 main.tex:211-213`).

**2. Internal Consistency**

- Two different LOSO meanings are used: `main.tex:107` is LOSO re-standardisation; `main.tex:331` imports Paper 07 LOSO feature discovery. Rename them.
- Source-vs-sensor numbers are mostly consistent, but source “strengthens” means effect size, not mean delta: source group delta `+1.54` is smaller than sensor `+1.67` (`main.tex:250`).
- `n:m` section contradicts itself: text/table say `4:1` not significant; figure caption says all ratios significant.
- Clinical replication is described as “comparable” in the abstract but “matches/same” in Results, figure caption, and falsifier.
- “We discuss outlier-subject diagnosis below” (`main.tex:134`) is not really fulfilled; only a limitation appears at `main.tex:352`.

**3. External Consistency**

- Paper 07 confirms the source EEG anchor, two-feature LOSO subset, `d_z=2.07`, Jaccard `1.00` (`07 main.tex:119-126`). Good.
- Paper 07 confirms clinical LOSO is smaller, `d_z=1.16`, `6/7` positive, Jaccard `0.52` (`07 main.tex:131-132`). Paper 06 must foreground this whenever it mentions clinical in-sample `d_z=1.98`.
- Paper 07’s current ledger is `15/16`, not `14/15` (`07 main.tex:33,40,213`). Paper 06 is outdated here.
- Paper 03 frames SL-002 as empirical support for the anaesthesia closure-disruption conditional (`03 main.tex:449-456`). Paper 06 undersells this programme role; add a brief relation sentence while preserving “not a consciousness theorem.”

**4. Narrative Coherence**

The paper now reads like a standalone neuroscience note more than SL-002 in a 10-paper programme. Add an early status box: “SL-002; empirical anchor for Paper 03 anaesthesia/CEMI bridge; proxy not operator; applicability later scoped by Paper 07.”

Align vocabulary with later papers: define “cortical closure residual / CCR” or explain how the 9-D feature vector becomes the residual reused by Papers 08-10. Also rename or explain `task_order`; in resting anaesthesia, “frontal-subnetwork order” is clearer than “task.”

**5. Tightness Edits**

- `main.tex:97`: “To rule out volume conduction” → “To test whether scalp-level volume conduction is the sole explanation”.
- `main.tex:227`: “cannot be explained” → “is not exhausted by a scalp-volume-conduction account”.
- `main.tex:258`: “clean test” → “source-level robustness check”.
- `main.tex:263`: “effect size matches” → “in-sample effect size is comparable; the honest LOSO estimate is smaller”.
- `main.tex:331`: “dominating ... by `5.5x`” → “Paper 07 reports `5.5x` for source full-feature in-sample closure vs scalar baseline; the LOSO two-feature subset is the stable cross-validated counterpart.”

**6. Surface Issues**

- `main.tex:218` caption is wrong.
- `main.tex:33,370` use `q<10^{-6}` incorrectly for beta-PGD.
- `main.tex:339` uses literal `§3.2`; use `\S\ref{...}` with a label.
- `main.tex:331`: “data was” → “data were”.
- `main.tex:359`: command shorthand `.propofol_source`, `.clinical_anesthesia_adapter` is not directly executable as written.
- Repository naming is inconsistent across the programme: Paper 06 uses `vfd-aria/solution-lab`; some companion refs use `vfd-org/solution-lab`.

**7. Top Three Fixes**

1. Fix LOSO/in-sample language everywhere: `main.tex:107`, `263`, `305`, `309`, `331`, `366`.
2. Correct hard numerical contradictions: `main.tex:218`, `33`, `370`, and the monotonicity claim at `201`.
3. Replace source-localisation “rule out / clean test” language with leakage-aware robustness language: `main.tex:97`, `227`, `254`, `258`.

**8. Programme-Strengthening Recommendations**

- Add explicit cross-reference to Paper 03’s anaesthesia conditional and state that SL-002 is empirical support, not proof of P-A or consciousness.
- Add a small “number map” table: sensor in-sample `1.90`, sensor LOSO-standardisation `1.87`, source in-sample `2.60`, Paper 07 source LOSO-feature-discovery `2.07`, clinical in-sample `1.98`, clinical LOSO `1.16`.
- Harmonise Paper 06 and Paper 07 ledger counts before release: `14/15` vs `15/16` is currently programme-inconsistent.
- Define the exported object reused by Papers 08-10: “SL-002 closure feature backend / CCR default pipeline.”

**9. Publication Ready?**

**No.** The central empirical result is close, but overclaiming remains around source localisation, clinical matched effect size, LOSO terminology, and Paper 07 attribution. Fix those and the paper can likely become publication-ready as a scoped empirical anchor.
